MADRID, Spain and ROCKVILLE,
Md., June 3, 2021 /PRNewswire/
-- Sandwalk BioVentures and CosmosID today announced the launch of
a new joint service offering for Generally-Recognized As Safe
(GRAS) regulatory genomic reporting for the Probiotics market in
the USA. By combining CosmosID's
end-to-end microbial genomics infrastructure with Sandwalk's
regulatory experience and expertise, developers of the next
generation of probiotics will now have access to an optimized
service offering. Through compliant sequencing, analysis and
reporting, the two companies aim to support the probiotics market
in fostering the next generation of functional bacterial
strains.
"It is a pleasure to partner up with CosmosID in this
initiative. We have worked with CosmosID in several GRAS dossiers
in the past and both companies had the feeling that probiotics
developers would enormously benefit from this turnkey solution. We
believe it is a great way to make genomic sequencing have an impact
across the board for probiotics companies – not only for their
R&D Departments but also for their Commercial and Regulatory
ones. Having a GRAS dossier is a legal requirement for all newcomer
probiotics in the US, so having the Genomic Reporting section of
the dossier as soon as possible and following FDA and industry
standards will certainly accelerate their time to market," said Dr.
Luis Gosalbez, Co-Founder & Managing Director of Sandwalk
BioVentures.
Manoj Dadlani, CEO of CosmosID,
commented: "CosmosID has been supporting probiotic and live
biotherapeutic companies with bacterial isolate sequencing and
analysis for a number of years. Now, through our partnership with
Sandwalk, we have the ability to now offer regulatory reporting to
our customers as well. Through this complete solution, we have all
of the necessary lab, bioinformatic and consulting expertise to
help bring novel microbial products to the market."
"The strategic partnership between CosmosID and Sandwalk
BioVentures will provide ease, convenience and value to customers
looking to unlock and commercialise microbiome-based products' said
Dr. Christian Roghi, Director of Strategic Alliances at
CosmosID.
The Genomic Sequencing and Reporting Bundle will consist of a
turnkey solution for probiotics developers by which they will
obtain not only the genomic sequence and analysis, but also a
complete, regulatory compliant report on the safety of their
strains for their GRAS dossiers, which are a legal requirement for
all new probiotics entering the US market.
More information about regulatory services can be found at
www.CosmosID.com.
About CosmosID
CosmosID®, based in Rockville, MD, provides solutions unlocking
the microbiome through the use of Next-Generation Sequencing (NGS)
and industry-leading bioinformatics solutions to achieve rapid
identification and characterization of microorganisms for
pharmaceutical R&D, molecular diagnostics, public health, food
safety, agriculture, and environmental applications. CosmosID's 11+
years of expertise enables end-to-end support of microbiome studies
including study design, sample collection, sample preparation, NGS,
bioinformatics and interpretation support. Available online,
CosmosID's cloud-based metagenomics application offers
user-friendly access to the world's largest curated database for
microbial with industry-leading sensitivity and precision. To learn
more please visit www.cosmosid.com.
About Sandwalk BioVentures
Sandwalk BioVentures is a specialty strategy, innovation,
regulatory and management consulting firm focused on microbiome
technologies. It supports companies in the food and pharma sectors,
as well as financial and strategic investors exploring to enter
this field. Sandwalk has extensive experience in helping start-ups
take their innovative microbiome technologies to market by
navigating the regulatory requirements in Europe and in the
United States.
To learn more please visit www.sandwalk.com.
Contacts
For SandWalk BioVentures:
Luis Gosalbez
311327@email4pr.com
For CosmosID:
Vickie Lord
703-995-9879
311327@email4pr.com
View original
content:http://www.prnewswire.com/news-releases/sandwalk-bioventures-and-cosmosid-launch-joint-gras-genomic-reporting-service-301304518.html
SOURCE CosmosID